이제환
#골수이식#골수구성백혈병#골수형성이상증후군
|
학력
1997 .03 ~ 2001 .08충북대학교 의학 박사
1995 .03 ~ 1997 .02울산대학교 의학 석사
1981 .03 ~ 1987 .02서울대학교 의학 학사
1995 .03 ~ 1997 .02울산대학교 의학 석사
1981 .03 ~ 1987 .02서울대학교 의학 학사
경력
2019 .03 ~ 현재울산의대 서울아산병원 내과장
2009 .03 ~ 2018 .02울산의대 서울아산병원 혈액암 및 골수이식센터 소장
2008 .04 ~ 현재울산의대 서울아산병원 혈액내과 교수
2003 .04 ~ 2008 .03울산의대 서울아산병원 혈액내과 부교수
2002 .08 ~ 2003 .07미국 Fred Hutchinson Cancer Research Center
1999 .04 ~ 2003 .03울산의대 서울아산병원 종양혈액내과 조교수
1997 .03 ~ 1999 .03울산의대 서울아산병원 종양혈액내과 전임강사
1996 .03 ~ 1997 .02울산의대 서울아산병원 종양혈액내과 전임강사대우
1994 .05 ~ 1996 .02울산의대 서울아산병원 종양혈액내과 전임의
1991 .04 ~ 1994 .04군복무(육군 군의관)
1988 .03 ~ 1991 .02서울대학교병원 내과 전공의
1987 .03 ~ 1988 .02서울대학교병원 수련의
논문
Prognostic impact of lymphocyte subpopulations in peripheral blood after hematopoietic stem cell transplantation for hematologic malignancies.
The detailed kinetics of cytomegalovirus-specific T cell responses after hematopoietic stem cell transplantation: 1 year follow-up data.
Allogeneic hematopoietic cell transplantation for lymphoma: baseline and posttransplant prognostic factors.
Benefits of hypomethylating therapy in IPSS lower-risk myelodysplastic syndrome patients: A retrospective multicenter case series study.
Clinical characteristics and outcomes of patients with chronic disseminated candidiasis who need adjuvant corticosteroid therapy.
Efficacy of eculizumab in paroxysmal nocturnal hemoglobinuria patients with or without aplastic anemia: prospective study of a Korean PNH cohort.
Epidemiology and Risk Factors for Invasive Fungal Diseases among Allogeneic Hematopoietic Stem Cell Transplant Recipients in Korea: Results of "RISK" Study.
Establishment and characterization of hypomethylating agent-resistant cell lines, MOLM/AZA-1 and MOLM/DEC-5.
Expression and prognostic significance of microRNAs in Korean patients with myelodysplastic syndrome.
Induction of immunoglobulin transcription factor 2 and resistance to MEK inhibitor in melanoma cells.
Prognostic significance of recurrent additional chromosomal abnormalities in adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Prospective Randomized Comparison of Idarubicin and High-Dose Daunorubicin in Induction Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia.
Salvage therapy for acute chemorefractory leukemia by allogeneic stem cell transplantation: the Korean experience.
Acute myeloid leukemia patient clinical response to idasanutlin (RG7388) is associated with pre-treatment MDM2 protein expression in leukemic blasts.
Allogeneic clonal mesenchymal stem cell therapy for refractory graft-versus-host disease to standard treatment: a phase I study.
Biweekly dose-dense gemcitabine-oxaliplatin and dexamethasone for relapsed/refractory aggressive non-Hodgkin lymphoma: A multicenter, single-arm, phase II trial.
Diagnostic usefulness of dynamic changes of CMV-specific T-cell responses in predicting CMV infections in HCT recipients.
Differences of cytomegalovirus diseases between kidney and hematopoietic stem cell transplant recipients during preemptive therapy.
Donor-Derived Natural Killer Cell Infusion after Human Leukocyte Antigen?Haploidentical Hematopoietic Cell Transplantation in Patients with Refractory Acute Leukemia
Dynamic prognostic value of the revised international prognostic scoring system following pretransplant hypomethylating treatment in myelodysplastic syndrome.
Evaluation of parameters obtained from the Sysmex XN-2000 for predicting the recovery of the absolute neutrophil count and platelets after hematopoietic stem cell transplantation.
Incidence, characteristics and treatment outcomes of mycobacterial diseases in transplant recipients.
Non-myeloablative conditioning for lower-risk myelodysplastic syndrome with bone marrow blasts less than 5%―a feasibility study
Predictive Factors of Mortality in Population of Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH): Results from a Korean PNH Registry.
Prospective validation of a novel dosing scheme for intravenous busulfan in adult patients undergoing hematopoietic stem cell transplantation.
A Phase II Trial of Fludarabine/Melphalan 100 Conditioning Therapy Followed by Allogeneic Hematopoietic Cell Transplantation for Patients With Lymphoma.
A prospective, multicenter phase II study of continuous infusion of FLAG for patients older than 60혻yr with resistant acute myeloid leukemia: a comparison with intensive younger patients' trial.
A prospective, multicenter, observational study of long-term decitabine treatment in patients with myelodysplastic syndrome
A t(8;9)(p22;p24)/PCM1-JAK2 translocation in a patient with myeloproliferative neoplasm and myeloid sarcoma: first report in Korea.
Biomarkers for hepatic sinusoidal obstruction syndrome after hematopoietic cell transplantation.
The detailed kinetics of cytomegalovirus-specific T cell responses after hematopoietic stem cell transplantation: 1 year follow-up data.
Allogeneic hematopoietic cell transplantation for lymphoma: baseline and posttransplant prognostic factors.
Benefits of hypomethylating therapy in IPSS lower-risk myelodysplastic syndrome patients: A retrospective multicenter case series study.
Clinical characteristics and outcomes of patients with chronic disseminated candidiasis who need adjuvant corticosteroid therapy.
Efficacy of eculizumab in paroxysmal nocturnal hemoglobinuria patients with or without aplastic anemia: prospective study of a Korean PNH cohort.
Epidemiology and Risk Factors for Invasive Fungal Diseases among Allogeneic Hematopoietic Stem Cell Transplant Recipients in Korea: Results of "RISK" Study.
Establishment and characterization of hypomethylating agent-resistant cell lines, MOLM/AZA-1 and MOLM/DEC-5.
Expression and prognostic significance of microRNAs in Korean patients with myelodysplastic syndrome.
Induction of immunoglobulin transcription factor 2 and resistance to MEK inhibitor in melanoma cells.
Prognostic significance of recurrent additional chromosomal abnormalities in adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Prospective Randomized Comparison of Idarubicin and High-Dose Daunorubicin in Induction Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia.
Salvage therapy for acute chemorefractory leukemia by allogeneic stem cell transplantation: the Korean experience.
Acute myeloid leukemia patient clinical response to idasanutlin (RG7388) is associated with pre-treatment MDM2 protein expression in leukemic blasts.
Allogeneic clonal mesenchymal stem cell therapy for refractory graft-versus-host disease to standard treatment: a phase I study.
Biweekly dose-dense gemcitabine-oxaliplatin and dexamethasone for relapsed/refractory aggressive non-Hodgkin lymphoma: A multicenter, single-arm, phase II trial.
Diagnostic usefulness of dynamic changes of CMV-specific T-cell responses in predicting CMV infections in HCT recipients.
Differences of cytomegalovirus diseases between kidney and hematopoietic stem cell transplant recipients during preemptive therapy.
Donor-Derived Natural Killer Cell Infusion after Human Leukocyte Antigen?Haploidentical Hematopoietic Cell Transplantation in Patients with Refractory Acute Leukemia
Dynamic prognostic value of the revised international prognostic scoring system following pretransplant hypomethylating treatment in myelodysplastic syndrome.
Evaluation of parameters obtained from the Sysmex XN-2000 for predicting the recovery of the absolute neutrophil count and platelets after hematopoietic stem cell transplantation.
Incidence, characteristics and treatment outcomes of mycobacterial diseases in transplant recipients.
Non-myeloablative conditioning for lower-risk myelodysplastic syndrome with bone marrow blasts less than 5%―a feasibility study
Predictive Factors of Mortality in Population of Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH): Results from a Korean PNH Registry.
Prospective validation of a novel dosing scheme for intravenous busulfan in adult patients undergoing hematopoietic stem cell transplantation.
A Phase II Trial of Fludarabine/Melphalan 100 Conditioning Therapy Followed by Allogeneic Hematopoietic Cell Transplantation for Patients With Lymphoma.
A prospective, multicenter phase II study of continuous infusion of FLAG for patients older than 60혻yr with resistant acute myeloid leukemia: a comparison with intensive younger patients' trial.
A prospective, multicenter, observational study of long-term decitabine treatment in patients with myelodysplastic syndrome
A t(8;9)(p22;p24)/PCM1-JAK2 translocation in a patient with myeloproliferative neoplasm and myeloid sarcoma: first report in Korea.
Biomarkers for hepatic sinusoidal obstruction syndrome after hematopoietic cell transplantation.
저서
저서 내용이 없습니다.
보도자료
보도자료 내용이 없습니다.
포스팅
Anti-leukemic effects of vosaroxin, an anti-cancer quinolone derivative, on hypomethylating agent resistant cells
Myeloid-Derived Suppressor Cells in Chronic Myelogenous Leukemia
The detailed kinetic data on cytomegalovirus (CMV)-specific T cell responses after hematopoietic stem cell transplantation: 1 year follow-up data
Inhibition of DNA methyltransferases by volasertib in HMA resistant cell lines
Treatment outcomes of myelodysplastic syndrome patients relapsing after allogeneic hematopoietic cell transplantation
Intravenous Busulfan-Based Conditioning Regimens in Allogeneic Hematopoietic Cell Transplantation for Patients with Acute Lymphoblastic Leukemia
Non-Myeloablative Conditioning for Lower-Risk Myelodysplastic Syndrome with Bone Marrow Blasts less than 5% ? a Feasibility Study
Frequency, Characteristics and Prognostic Significance of RUNX1 Mutations in Patients with Acute Myeloid Leukemia, Not Otherwise Specified
Identification of novel fusion genes and differentially expressed genes in acute leukemia through transcriptome analysis
Frequency, Characteristics and Prognostic Significance of RUNX1 Mutations in Patients with Acute Myeloid Leukemia, Not Otherwise Specified
Expression of JL1 Antigen in Acute Leukemia and Myelodysplastic Syndrome
Frequency, Characteristics, and Prognostic Significance of RUNX1 Mutations in Patients with Acute Myeloid Leukemia, Not Otherwise Specified
Alternating Appearance of Acute Promyelocytic Leukemia and Secondary Myelodysplastic Syndrome: Case Report
Bone Marrow Histopathology with Gene Mutational Correlation in Patients with Essential Thrombocythemia and Primary Myelofibrosis
The t(8;9)(p22;p24) Translocation in Myeloproliferative Neoplasm associated with Myeloid Sarcoma
Predictive Value of Post-transplant Molecular Minimal Residual Disease Monitoring Versus Pretreatment Risk Factors in Patients with Favorable Risk Acute Myeloid Leukemia Following Hematopoietic Stem Cell Transplantation
A Case of de novo Aleukemic Mast Cell Leukemia Without c-KIT Mutations in Exon 8 and 17
A Case of Refractory Anemia with Ring Sideroblasts associated with marked Thrombocytosis
Simplified Immunophenotyping Panel for Multiple Myeloma to differentiate neoplastic myeloma cells from reactive plasma cells
Changes of Hematopoietic Microenvironment and Lymphocytes in Hematopoietic Stem Cell Transplantation of Acute Lymphoblastic Leukemia: Comparison between Relapse and Non-relapse groups
Myeloid-Derived Suppressor Cells in Chronic Myelogenous Leukemia
The detailed kinetic data on cytomegalovirus (CMV)-specific T cell responses after hematopoietic stem cell transplantation: 1 year follow-up data
Inhibition of DNA methyltransferases by volasertib in HMA resistant cell lines
Treatment outcomes of myelodysplastic syndrome patients relapsing after allogeneic hematopoietic cell transplantation
Intravenous Busulfan-Based Conditioning Regimens in Allogeneic Hematopoietic Cell Transplantation for Patients with Acute Lymphoblastic Leukemia
Non-Myeloablative Conditioning for Lower-Risk Myelodysplastic Syndrome with Bone Marrow Blasts less than 5% ? a Feasibility Study
Frequency, Characteristics and Prognostic Significance of RUNX1 Mutations in Patients with Acute Myeloid Leukemia, Not Otherwise Specified
Identification of novel fusion genes and differentially expressed genes in acute leukemia through transcriptome analysis
Frequency, Characteristics and Prognostic Significance of RUNX1 Mutations in Patients with Acute Myeloid Leukemia, Not Otherwise Specified
Expression of JL1 Antigen in Acute Leukemia and Myelodysplastic Syndrome
Frequency, Characteristics, and Prognostic Significance of RUNX1 Mutations in Patients with Acute Myeloid Leukemia, Not Otherwise Specified
Alternating Appearance of Acute Promyelocytic Leukemia and Secondary Myelodysplastic Syndrome: Case Report
Bone Marrow Histopathology with Gene Mutational Correlation in Patients with Essential Thrombocythemia and Primary Myelofibrosis
The t(8;9)(p22;p24) Translocation in Myeloproliferative Neoplasm associated with Myeloid Sarcoma
Predictive Value of Post-transplant Molecular Minimal Residual Disease Monitoring Versus Pretreatment Risk Factors in Patients with Favorable Risk Acute Myeloid Leukemia Following Hematopoietic Stem Cell Transplantation
A Case of de novo Aleukemic Mast Cell Leukemia Without c-KIT Mutations in Exon 8 and 17
A Case of Refractory Anemia with Ring Sideroblasts associated with marked Thrombocytosis
Simplified Immunophenotyping Panel for Multiple Myeloma to differentiate neoplastic myeloma cells from reactive plasma cells
Changes of Hematopoietic Microenvironment and Lymphocytes in Hematopoietic Stem Cell Transplantation of Acute Lymphoblastic Leukemia: Comparison between Relapse and Non-relapse groups
영상자료
영상자료 내용이 없습니다.
발표자료
골수형성이상증후군 골수생검에서 면역조직화학염색으로 시행한 CD34 및 p53 발현양상과 예후와의 연관성
Alemtuzumab treatment for aplastic anemia (AA) and low-risk myelodysplastic syndrome (MDS): preliminary results
진성적혈구증다증에서 hydroxyurea 치료 후 골수증식성질환/골수이형성증후군-미분류로 전환된 1례 보고
CD34 및 p53 면역조직화학염색을 이용한 저세포성 골수형성이상증후군과 재생불량성빈혈의 감별진단
HLA-HAPLOIDENTICAL FAMILIAL DONOR HEMATOPOIETIC CELL TRANSPLANTATION WITHOUT EX VIVO- T CELL DEPLETION AFTER REDUCED-INTENSITY CONDITIONING OF BUSULFAN, FLUDARABINE, AND ANTI-THYMOCYTE GLOBULIN
C3435T polymorphism of MDR1 gene is not associated with p-glycoprotein function of leukemic blasts and clinical outcomes in patients with acute myeloid leukemia
Preliminary results of a prospective multicenter phase III trial comparing high-dose and standard-dose daunorubicin for induction of complete remission (CR) in acute myeloid leukemia (AML)
Detection for FLT3 D835 and internal tandem duplication (ITD) mutation in adult acute non T-cell lymphoblastic leukemia
급성골수성백혈병 환자 612명에서 세포유전학적 아형의 연령 특이적 고찰
급성림프아구성백혈병에서 형태학적 관해 후 유세포분석을 이용한 미세잔존백혈병의 예후인자로서의 의의
CML 환자에서 der(9) 상의 BCR과 ABL 유전자의 결실 빈도 및 임상적, 혈액학적, 세포유전학적, 예후와의 상관성 연구
Prognostic significance of FLT3 mutation in paired initial and relapse marrow samples of acute myeloid leukemia
3q21q26 Syndrome의 혈액학적, 임상적 소견: 매우 불량한 예후와 중추성 요붕증과의 연관성
급성 림프구성 백혈병에서 형태학적 관해 후 유세포분석을 이용한 미세잔존백혈병의 예후인자로서의 의의
급성양표현성백혈병의 혈액학적 양상, 면역표현형 및 세포유전학적 소견이 예후에 미치는 영향
Prognostic implications of the immunophenotype in biphenotypic acute leukemia
3‘CBFB 결실이 동반된 t(16;16)을 가지는 급성골수성백혈병(AML M4대) 1예
급성 골수성 백혈병에서 형태학적 관해 후 유세포분석을 이용한 미세잔존백혈병 측정의 의의
Alemtuzumab treatment for aplastic anemia (AA) and low-risk myelodysplastic syndrome (MDS): preliminary results
진성적혈구증다증에서 hydroxyurea 치료 후 골수증식성질환/골수이형성증후군-미분류로 전환된 1례 보고
CD34 및 p53 면역조직화학염색을 이용한 저세포성 골수형성이상증후군과 재생불량성빈혈의 감별진단
HLA-HAPLOIDENTICAL FAMILIAL DONOR HEMATOPOIETIC CELL TRANSPLANTATION WITHOUT EX VIVO- T CELL DEPLETION AFTER REDUCED-INTENSITY CONDITIONING OF BUSULFAN, FLUDARABINE, AND ANTI-THYMOCYTE GLOBULIN
C3435T polymorphism of MDR1 gene is not associated with p-glycoprotein function of leukemic blasts and clinical outcomes in patients with acute myeloid leukemia
Preliminary results of a prospective multicenter phase III trial comparing high-dose and standard-dose daunorubicin for induction of complete remission (CR) in acute myeloid leukemia (AML)
Detection for FLT3 D835 and internal tandem duplication (ITD) mutation in adult acute non T-cell lymphoblastic leukemia
급성골수성백혈병 환자 612명에서 세포유전학적 아형의 연령 특이적 고찰
급성림프아구성백혈병에서 형태학적 관해 후 유세포분석을 이용한 미세잔존백혈병의 예후인자로서의 의의
CML 환자에서 der(9) 상의 BCR과 ABL 유전자의 결실 빈도 및 임상적, 혈액학적, 세포유전학적, 예후와의 상관성 연구
Prognostic significance of FLT3 mutation in paired initial and relapse marrow samples of acute myeloid leukemia
3q21q26 Syndrome의 혈액학적, 임상적 소견: 매우 불량한 예후와 중추성 요붕증과의 연관성
급성 림프구성 백혈병에서 형태학적 관해 후 유세포분석을 이용한 미세잔존백혈병의 예후인자로서의 의의
급성양표현성백혈병의 혈액학적 양상, 면역표현형 및 세포유전학적 소견이 예후에 미치는 영향
Prognostic implications of the immunophenotype in biphenotypic acute leukemia
3‘CBFB 결실이 동반된 t(16;16)을 가지는 급성골수성백혈병(AML M4대) 1예
급성 골수성 백혈병에서 형태학적 관해 후 유세포분석을 이용한 미세잔존백혈병 측정의 의의